MedTrace Logo

Diagnosis of EIB in Young Elite Athletes (13-18 y)

NCT03587675 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2021-11-05

No results posted yet for this study

Summary

The investigators recently observed airway inflammation and increased damage-associated molecular pattern (DAMP) level in sputum of children (age 11-12y) and adolescents (18-23y) from elite sport programs in Belgium with increased risk of bronchoconstriction upon extreme exercise. They here want to validate these findings in a cohort 13-18y.

Conditions

  • Exercise Induced Bronchospasm
  • Athletes
  • Adolescent

Interventions

DIAGNOSTIC_TEST

EVH test

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Dominique MA Bullens, MD, PhD · Lab pediatric Immunology, Dep Microbiology and Immunology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2021-11-30
Completion
2022-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587675 on ClinicalTrials.gov